Soleno Therapeutics Stock Market Value
| SLNO Stock | USD 38.99 0.38 0.98% |
| Symbol | Soleno |
Will Biotechnology sector continue expanding? Could Soleno diversify its offerings? Factors like these will boost the valuation of Soleno Therapeutics. If investors know Soleno will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Soleno Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Soleno Therapeutics requires distinguishing between market price and book value, where the latter reflects Soleno's accounting equity. The concept of intrinsic value - what Soleno Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Soleno Therapeutics' price substantially above or below its fundamental value.
Please note, there is a significant difference between Soleno Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Soleno Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Soleno Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Soleno Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Soleno Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Soleno Therapeutics.
| 11/21/2025 |
| 02/19/2026 |
If you would invest 0.00 in Soleno Therapeutics on November 21, 2025 and sell it all today you would earn a total of 0.00 from holding Soleno Therapeutics or generate 0.0% return on investment in Soleno Therapeutics over 90 days. Soleno Therapeutics is related to or competes with Praxis Precision, Dyne Therapeutics, Ascentage Pharma, Apogee Therapeutics, Centessa Pharmaceuticals, Xenon Pharmaceuticals, and Ultragenyx. Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization ... More
Soleno Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Soleno Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Soleno Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 15.78 | |||
| Value At Risk | (4.39) | |||
| Potential Upside | 5.07 |
Soleno Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Soleno Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Soleno Therapeutics' standard deviation. In reality, there are many statistical measures that can use Soleno Therapeutics historical prices to predict the future Soleno Therapeutics' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.33) | |||
| Total Risk Alpha | (0.43) | |||
| Treynor Ratio | (0.22) |
Soleno Therapeutics February 19, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.21) | |||
| Mean Deviation | 2.51 | |||
| Coefficient Of Variation | (1,200) | |||
| Standard Deviation | 3.24 | |||
| Variance | 10.48 | |||
| Information Ratio | (0.1) | |||
| Jensen Alpha | (0.33) | |||
| Total Risk Alpha | (0.43) | |||
| Treynor Ratio | (0.22) | |||
| Maximum Drawdown | 15.78 | |||
| Value At Risk | (4.39) | |||
| Potential Upside | 5.07 | |||
| Skewness | 0.7231 | |||
| Kurtosis | 0.6338 |
Soleno Therapeutics Backtested Returns
Soleno Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0656, which indicates the firm had a -0.0656 % return per unit of risk over the last 3 months. Soleno Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Soleno Therapeutics' Coefficient Of Variation of (1,200), risk adjusted performance of (0.06), and Variance of 10.48 to confirm the risk estimate we provide. The entity has a beta of 1.28, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Soleno Therapeutics will likely underperform. At this point, Soleno Therapeutics has a negative expected return of -0.21%. Please make sure to validate Soleno Therapeutics' skewness, as well as the relationship between the day median price and relative strength index , to decide if Soleno Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.27 |
Poor predictability
Soleno Therapeutics has poor predictability. Overlapping area represents the amount of predictability between Soleno Therapeutics time series from 21st of November 2025 to 5th of January 2026 and 5th of January 2026 to 19th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Soleno Therapeutics price movement. The serial correlation of 0.27 indicates that nearly 27.0% of current Soleno Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.27 | |
| Spearman Rank Test | 0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 4.25 |
Pair Trading with Soleno Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Soleno Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Soleno Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Soleno Stock
Moving against Soleno Stock
| 0.84 | DRTS | Alpha Tau Medical | PairCorr |
| 0.75 | 8VP1 | AVRICORE HEALTH INC | PairCorr |
| 0.75 | 6C1 | CytomX Therapeutics | PairCorr |
| 0.72 | VALN | Valneva SE ADR | PairCorr |
| 0.68 | GXEA | Galapagos NV Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Soleno Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Soleno Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Soleno Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Soleno Therapeutics to buy it.
The correlation of Soleno Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Soleno Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Soleno Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Soleno Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Soleno Therapeutics Correlation, Soleno Therapeutics Volatility and Soleno Therapeutics Performance module to complement your research on Soleno Therapeutics. To learn how to invest in Soleno Stock, please use our How to Invest in Soleno Therapeutics guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Soleno Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.